Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor backend update with no changes to the displayed study information.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision has been updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a software revision with no impact on study data, content, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedFooter shows Revision: v3.3.4 after removing v3.3.3, a minor metadata update that does not affect study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check121 days agoChange DetectedAdded a dedicated Locations section listing California and Massachusetts sites for the study. The page now includes a revision note (Revision: v3.3.3) and the separate 'California Locations' and 'Massachusetts Locations' entries were removed.SummaryDifference0.3%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.